Stock Events
Stock Events
Features
Business
More
Login
Sign Up
Sign Up
CRISPR Therapeutics
(CRSP) Q3 2025
Earnings
CRSP
Aug 4
Confirmed
Q4 2024
Q1 2025
Q2 2025
Q3 2025
-2.4
-1.75
-1.09
-0.44
Details
Expected EPS
-1.401529
Actual EPS
-2.4
Surprise EPS
-1
Surprise Percent
-71.24%
Description
CRISPR Therapeutics (CRSP) has reported earnings of -2.4 per share for Q3 2025.
0 Comments
Share your thoughts
Get the Stock Events App
Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.
Sign Up
Login